| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
23,158 |
19,994 |
$738K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
1,598 |
1,519 |
$115K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
1,272 |
1,238 |
$92K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
1,189 |
1,087 |
$84K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
1,160 |
1,128 |
$82K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
3,954 |
3,874 |
$39K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
556 |
526 |
$24K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
687 |
648 |
$24K |
| 92587 |
|
2,207 |
2,152 |
$20K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,406 |
1,364 |
$19K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
245 |
237 |
$15K |
| 99173 |
|
2,673 |
2,237 |
$15K |
| 87428 |
|
469 |
449 |
$15K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
219 |
217 |
$14K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
2,392 |
2,336 |
$13K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,149 |
724 |
$8K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
1,157 |
969 |
$6K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
148 |
144 |
$3K |
| 0002A |
|
82 |
82 |
$2K |
| 0001A |
|
80 |
77 |
$2K |
| 99072 |
|
886 |
778 |
$2K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
236 |
202 |
$2K |
| 99383 |
|
16 |
16 |
$1K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
49 |
49 |
$1K |
| 90633 |
|
111 |
108 |
$565.50 |
| 90651 |
|
134 |
131 |
$489.34 |
| 99441 |
|
43 |
36 |
$343.56 |
| 90656 |
|
177 |
174 |
$330.63 |
| 87807 |
|
12 |
12 |
$221.63 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
18 |
18 |
$181.86 |
| 81002 |
|
25 |
25 |
$80.53 |
| 90734 |
|
44 |
42 |
$70.00 |
| 91300 |
|
159 |
142 |
$30.00 |
| 90710 |
|
29 |
29 |
$20.00 |
| 90620 |
|
12 |
12 |
$10.00 |
| 96160 |
|
592 |
550 |
$0.00 |
| 90715 |
|
15 |
15 |
$0.00 |
| 90648 |
|
12 |
12 |
$0.00 |
| 90670 |
|
40 |
39 |
$0.00 |
| H0049 |
Alcohol and/or drug screening |
16 |
16 |
$0.00 |
| 96127 |
|
119 |
109 |
$0.00 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
110 |
99 |
$0.00 |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
26 |
25 |
$0.00 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
16 |
16 |
$0.00 |
| J7644 |
Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram |
16 |
16 |
$0.00 |